|
|
Volumn 65, Issue 19, 2008, Pages 1788-
|
|
FDA approves thrombopoiesis-stimulating agent
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
IMMUNOGLOBULIN;
NPLATE;
REMIPLISTIM;
THROMBOPOIETIN;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ARTHRALGIA;
CORTICOSTEROID THERAPY;
DIZZINESS;
DRUG APPROVAL;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG FORMULATION;
DRUG INDICATION;
DRUG LABELING;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
HEADACHE;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
IMMUNOTHERAPY;
INSOMNIA;
LIMB PAIN;
MYALGIA;
NOTE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SHOULDER PAIN;
SPLENECTOMY;
THROMBOCYTE COUNT;
THROMBOCYTOPOIESIS;
TREATMENT FAILURE;
|
|
EID: 54749114068
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news080078 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|